Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 31.50B | 38.66B | 31.96B | 34.16B | 33.14B | 27.16B |
Gross Profit | 7.77B | 9.06B | 7.60B | 9.03B | 8.39B | 6.21B |
EBITDA | 6.59B | 7.79B | 6.29B | 7.83B | 7.32B | 5.28B |
Net Income | 2.81B | 3.28B | 2.40B | 3.83B | 3.46B | 2.35B |
Balance Sheet | ||||||
Total Assets | 56.83B | 65.86B | 59.52B | 51.11B | 46.89B | 43.52B |
Cash, Cash Equivalents and Short-Term Investments | 3.52B | 3.60B | 3.65B | 3.25B | 3.68B | 3.79B |
Total Debt | 21.18B | 28.55B | 23.02B | 18.52B | 18.55B | 20.55B |
Total Liabilities | 35.74B | 41.03B | 37.70B | 31.46B | 30.82B | 30.73B |
Stockholders Equity | 21.10B | 24.83B | 21.82B | 19.64B | 16.06B | 12.79B |
Cash Flow | ||||||
Free Cash Flow | 5.77B | -4.12B | -3.02B | -29.69M | 2.39B | -1.27B |
Operating Cash Flow | 5.77B | 6.79B | 4.57B | 3.66B | 5.81B | 4.42B |
Investing Cash Flow | 0.00 | -11.97B | -7.59B | -3.27B | -3.42B | -5.69B |
Financing Cash Flow | 0.00 | 5.19B | 3.60B | -406.16M | -2.56B | 1.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥22.11B | 8.77 | 4.05% | 6.41% | -3.59% | ||
77 Outperform | ¥32.19B | 11.75 | 0.13% | 9.61% | 53.78% | ||
76 Outperform | ¥31.89B | 6.41 | 4.11% | 3.47% | 33.32% | ||
76 Outperform | ¥60.23B | 13.16 | 1.83% | 5.20% | -1.83% | ||
68 Neutral | ¥41.75B | 16.62 | 0.76% | 14.95% | -10.67% | ||
61 Neutral | $10.37B | 6.45 | -0.08% | 2.84% | 3.09% | -36.03% | |
52 Neutral | ¥35.43B | 94.32 | 4.16% | -3.77% | -315.45% |